Sort   by:  
 Page size 
UnknownIn vitro effects of histamine receptor 1 antagonists on proliferation and histamine release in canine neoplastic mast cells.
Not available
S-EPMC7840218 | biostudies-literature
UnknownEffects of ibrutinib on proliferation and histamine release in canine neoplastic mast cells.
Not available
S-EPMC6900099 | biostudies-literature
UnknownEvaluation of cooperative antileukemic effects of nilotinib and vildagliptin in Ph+ chronic myeloid leukemia.
Not available
S-EPMC7115814 | biostudies-literature
UnknownA kinase profile-adapted drug combination elicits synergistic cooperative effects on leukemic cells carrying BCR-ABL1T315I in Ph+ CML.
Not available
S-EPMC6834439 | biostudies-literature
UnknownIdentification of CD203c as a New Basophil-Specific Flow-Marker in Ph<sup>+</sup> Chronic Myeloid Leukemia.
Not available
S-EPMC9818308 | biostudies-literature
UnknownThe pan-BCL-2-blocker obatoclax (GX15-070) and the PI3-kinase/mTOR-inhibitor BEZ235 produce cooperative growth-inhibitory effects in ALL cells.
Not available
S-EPMC5620205 | biostudies-literature
UnknownBTK inhibition is a potent approach to block IgE-mediated histamine release in human basophils.
Not available
S-EPMC5655929 | biostudies-literature
UnknownN-terminal pro-brain natriuretic peptide is a prognostic marker for response to intensive chemotherapy, early death, and overall survival in acute myeloid leukemia.
Not available
S-EPMC10107495 | biostudies-literature
UnknownIdentification of Ponatinib as a potent inhibitor of growth, migration, and activation of neoplastic eosinophils carrying FIP1L1-PDGFRA.
Not available
S-EPMC4338611 | biostudies-literature
UnknownTarget interaction profiling of midostaurin and its metabolites in neoplastic mast cells predicts distinct effects on activation and growth.
Not available
S-EPMC4896384 | biostudies-literature
Sort   by:  
 Page size